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326a Monday, February 17, 2014metabolite, had a higher affinity than fluoxetine, with an IC50 of 29 mM.
Fluoxetine inhibited currents in a frequency-dependent manner, shifted
steady-state inactivation to more hyperpolarized potentials, and slowed the
recovery of Nav1.5 channels from inactivation. Mutating a phenylalanine
(F1760) and a tyrosine (Y1767) in DIV S6, two amino acid residues known
to be essential for class 1 antiarrhythmic drug binding, significantly reduced
the affinity of fluoxetine and its frequency-dependent inhibition. We used a
non-activating Nav1.5 mutant to show that fluoxetine displays open-
channel block behavior. We concluded that fluoxetine blocks Nav1.5 chan-
nels by binding to the class 1 antiarrhythmic site. The blocking of cardiac
Naþ channels should be taken into consideration when prescribing fluoxetine
alone or in association ith other drugs that may be cardiotoxic or for patients
with conduction dsorders.
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The pore-forming a subunit of the voltage-gated Naþ (Nav) channels (Nav1.1-
Nav1.9) provides the basis for electrical excitability in the brain. These Nav
channels are regulated by a number of accessory proteins. One of the important
regulator of Nav channels is intracellular fibroblast growth factor 14 (FGF14), a
member of not-secreted intracellular FGFs (iFGFs; FGF11-13). This iFGF14
acts as an allosteric modulator of the Nav channel and regulates neuronal excit-
ability by controlling Nav channel gating properties and expression.
In pursuit of drug discovery against the FGF14-Nav1.6 channel complex, we
are combining molecular modeling to design peptide-fragments of FGF14,
split-luciferase complementation assay (LCA) to evaluate the potency of these
peptides, and electrophysiology to further validates these peptides as disrupters
of the FGF14/Nav1.6 channel complex. We already have created a FGF14
dimer homology model based on the FGF13 dimer crystal structure and
have showed with in-cell LCA that the FGF14 monomer: monomer interface
overlaps with the FGF14/Nav channel interface. We have also identified key
amino acids in proximity to the FGF14/Nav1.6 interface and show that muta-
tions at these sites affect the Nav channel assembly with the FGF14 monomer
and control the access of small fragment peptides to the interface. Based on
our preliminary data, we hypothesize that FGF14-peptide fragments
mimicking the FGF14 protein will compete with FGF14 for binding to Nav
channels and serve as potential chemical leads for drug development against
Nav channels. The proposed small peptides based on the FGF14:Nav1.6
protein-protein interactions act as allosteric modulators for the Nav channel
functions. These results will provide fundamental new knowledge for the
design of new leads targeting the FGF14/Nav channel complex as a novel
drugs target interface.
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Voltage-dependent sodium channels (Nav1.X) control the rising phase of ac-
tion potentials in excitable cells. Mutational pathologies include epilepsy,
Long QT syndrome, familial autism, and pain insensitivity. This family of
ion channels is regulated by calmodulin (CaM), a small, essential eukaryotic
calcium sensor that contains two highly homologous domains whose affinities
for calcium differ by an order of magnitude. CaM is known to recognize at least
two regions of NaV: the highly conserved inactivation gate between transmem-
brane domains III and IV, and an IQ motif, located in the intracellular C-termi-
nus of the Nav. The IQ motif, which may serve as a CaM ‘‘sink’’, holds CaM
available to quickly re-associate with the inactivation gate upon calcium bind-
ing. High-resolution structures of apo CaM bound to the IQ motifs of NaV1.2,
1.5 and 1.6 show many similarities. However, the free energies of CaM binding
to these motifs are markedly different. In our studies of CaM binding to the IQ
motif of NaV1.2, the C-domain of both apo (calcium-free) and calcium-
saturated CaM bind and calcium binding to CaM lowers its affinity for the
IQ motif. To better understand calcium-mediated feedback control, we con-
ducted thermodynamic analyses of CaM binding to the IQ motif sequences rep-
resenting all 9 members of the human Nav family and the consensus
inactivation gate. CaM binding was detected by monitoring the loss of FRET
intensity of a biosensor containing the IQ motif sandwiched between twoYFP and CFP. The nine sodium channels split into two classes based on their
binding affinity for apo CaM at the IQ motif. We are exploring the roles of in-
dividual residues to determine the positions that are necessary and sufficient to
confer preferential binding of apo or calcium-saturated CaM. Support: NIH
R01 GM57001.
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Voltage-gated Naþ channels (NaChs) are common targets for anti-epileptic
drugs due to their role in the initiation and propagation of action potentials
in central neurons. NaCh blocking agents, such as phenytoin and lamotrigine,
act by blocking peak Naþ current (INa) in voltage- and frequency- dependent
manner. A recent study showed that GS-458967 (GS967) is a potent blocker of
cardiac INa. However, the effects of GS967 on neuronal INa and action poten-
tials were not examined. Thus, using isolated rat cultured hippocampal neurons,
effects of GS967 on neuronal INa and excitability were determined. GS967
(10-1000 nM) caused a voltage- (60 mV) and frequency (10 Hz)-dependent
block of INa with IC50 values of 40.654.0 (n=4, at each concentration) and
477.0553.0 nM (n=4, at each concentration), respectively. However, tonic
block of INa was minimal (7.650.5 % at 1000 nM, n= 4). GS967 decreased
the sustained repetitive firing (SRF) in response to a 1-sec depolarizing current
injection with an IC50 value of 47.852.8 nM (n=3-4, at each concentration).
Consistent with minimal tonic block of INa, the compound had no effect on
the amplitude of the first action potential during SRF (2.250.8 % at 300
nM). Furthermore, GS967 reversibly reduced the epileptiform activity induced
by NMDA activation (removal of extracellular Mg2þ) with an IC50 value of
50.751.4 nM (n=3-5, at each concentration). In addition, the effects of
GS967 on ligand-gated ion channels that are essential for synaptic inhibition
or excitation were tested. GS967 (1000 nM) had no effect on GABA-
activated currents (4.253.4%, n=8). At 1000 nM, GS967 inhibited NMDA-
activated currents by 18.256.2% (n=5). Taken together, these findings provide
preliminary evidence that GS967 could be effective in controlling abnormal
neuronal firing.
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Objective: Mutations in SCN5A, the gene encoding the cardiac sodium chan-
nel, have been linked to many inherited cardiac arrhythmias. We have shown
the existence of dominant-negative mutations in Brugada Syndrome due to in-
teractions between alpha-subunits. Here we investigated whether cardiac so-
dium channel alpha-subunits also display coupled gating in addition to
interacting.
Methods: Biophysical properties were studied by patch-clamp analysis in the
whole-cell configuration.
Results: We used a non-trafficking mutant which can be rescued with mexili-
tine, unveiling a þ15 mV shift in activation compared to WT. When this non-
trafficking mutant was co-expressed with WT, we still saw a shift in activation
compared to WT alone, even though the mutant is not conducting. Therefore
these results demonstrate that the presence of the mutant, affects the activation
of the WT suggesting a gating cooperation between the 2 channels. Then we
wanted to address whether the inactivation gating process was also synergic be-
tween two sodium channel subunits. We used a channel where the C-terminus
was deleted and where inactivation was affected. Expression of this delta-Cter
alone showed altered inactivation kinetics. Surprisingly, when co-transfected
with the trafficking-competent but gating-deficient mutant channel R878C,
the inactivation properties of the mutant were partially rescued. Altogether
these data suggest that the presence of the full C-terminal region provided by
the nonfunctional channel R878C could rescue the inactivation defect of the
delta-Cter channel.
Conclusions: Mutations impairing either activation or inactivation of one
channel can affect the gating properties of the other WT alpha-subunit demon-
strating coupled gating properties between sodium channel alpha-subunits.
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Cinnamaldehyde (CA) is a highly reactive compound that has been used in
experimental models of neurogenic inflammation as specific agonist of the
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mice and humans, we have found that CA only produces very weak avoidance,
pain or visceral irritation responses. Furthermore, CA induces a dramatic
decrease in the velocity of conduction and the amplitude of compound action
potentials in the mouse tail. Noting the structural similarities between CA and
classical local anesthetics, we investigated whether CA inhibits voltage-gated
sodium channels (VGSC) expressed in sensory neurons. We found that CA in-
hibits TTX-sensitive voltage-dependent sodium currents in a concentration
dependent manner in mouse trigeminal neurons with an IC50 of 1.5 mM.
TTX-resistant sodium currents were inhibited with an IC50 of 0.8 mM.
TTX-sensitive VGSC recorded in the immortalized DRG neuron-derived
F11 cells were inhibited with an IC50 of 1.3 mM. CA modified the gating
of TTX-sensitive sodium channels, inducing concentration-dependent shifts
of the activation curve to depolarized voltages and shifts of the availability
curve to more hyperpolarized voltages. In the presence of CA, the correspond-
ing slope factors became significantly larger. CA-induced inhibition was
enhanced at depolarized holding potentials. Inhibition of TTX-sensitive so-
dium channels was not frequency dependent and can occur when the channels
are in resting/closed state(s). We conclude that CA inhibits VGSC in sensory
neurons at concentrations that can be pharmacologically relevant, and that the
mechanism of inhibition shares similarities with the action of local
anesthetics.
1659-Pos Board B389
Acidosis: A Possible Trigger for Brugada Syndrome Associated
Arrhythmia
Colin H. Peters, Peter C. Ruben.
Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
Brugada Syndrome (BrS) is an inherited cardiac arrhythmia implicated in
SIDS and sudden death in young men. BrS is caused by loss-of-function mu-
tations in the cardiac voltage-gated sodium channel NaV1.5. The decrease in
sodium current can lead to electrical abnormalities in the ventricular action po-
tential that can degenerate into ventricular tachycardia. The ECG phenotype
and electrical abnormalities associated with BrS are not always present and
are often unmasked clinically with sodium channel blockers. Paradoxically,
BrS associated arrhythmias manifest during and after exercise as well as in
sleeping infants. We hypothesize that one trigger for arrhythmias in BrS
may be extracellular acidosis, which can occur during both exercise and sleep
apnea. We used whole-cell patch clamp to characterize 3 BrS mutants, R376H,
R1193Q, and E1784K, at pH 7.4 and pH 6.0. At pH 7.4 all mutants have
reduced current compared to WT channels and there are changes in channel
activation and fast inactivation. At pH 6.0, E1784K showed the largest
proton-dependent effect with a 20 mV depolarizing shift in the midpoint
voltage of activation compared to the 12 mV shift in WT. All 3 mutants
showed decreased function at pH 6.0 although the magnitude of the shifts
was not always different fromWT. Overall, extracellular acidosis would be ex-
pected to challenge already decreased sodium currents, particularly in the
E1784K mutant. Therefore, acidosis may be one of the triggers for arrhythmia
in BrS patients.
1660-Pos Board B390
Inal in the Pathophysiology of Insulin-Secretion: A ‘‘Cardiac’’ Paradigm
in a New Cell Type
Riccardo Rizzetto, Marcella Rocchetti, Alice Villa, Luca Sala,
Carlotta Ronchi, Isabella Molinari, Mara Ferrandi, Antonio Zaza.
Universita` di Milano Bicocca, Milano, Italy.
BACKGROUND: enhancement of the sustained component of the sodium cur-
rent (INaL) is a major factor contributing to myocardial damage. A beneficial
effect of the INaL blocker Ranolazine (RAN) on glycemic control was recently
described in the MERLIN-TIMI 36 trial in diabetic patients. However, the
mechanism underlying this finding hasn’t been elucidated yet.
AIM: To characterize INaL in insulin-secreting cells (INS-1E) and evaluate its
role in glucose-stimulated insulin secretion (GSIS).
METHODS: INaL, identified as the steady-state current blocked by 10 mM
RAN (IRAN) or 0.5 mM TTX (ITTX), and its impact on membrane potential
(Vm) were assessed by patch clamp. Veratridine (VERA) was used as INaL
enhancer. INaL-dependent intracellular Ca2þ changes were detected by Fluo-
4AM. To simulate hyperglycemic stress (CHG), INS-1E cells were exposed
to 33 mM glucose for 24 hrs. GSIS was measured by HTRF assay.
RESULTS: Glucose- and tolbutamide-triggered action potentials were sup-
pressed by TTX, but not by RAN. VERA caused depolarization, countered
by INaL blockade. The reversal potentials of ITTX and IRAN were negative
to Naþ equilibrium potential, but they approached it when Kþ-channels
were blocked. This revealed INaL coupling to Naþ-activated Kþ current
(IKNa); expression of IKNa channels (Slo2.1/2.2) was confirmed by transcriptanalysis. INaL blockade blunted cytosolic Ca2þ response to depolarization.
CHG enhanced INaL. Whereas acute INaL enhancement (VERA) increased
GSIS, chronic one (CHG or VERA) depressed GSIS, which was partially
restored by RAN.
CONCLUSIONS: INaL is expressed in insulin-secreting cells, is coupled to
IKNa , affects Ca2þ signalling and, when enhanced acutely, increases GSIS.
However, constitutive INaL enhancement, induced by chronic hyperglycemic
stress, and leads to GSIS depression instead. Overall, chronic INaL enhance-
ment may represent a mechanism of damage progression common to myocar-
dial and insulin-secreting cells.
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Cardiac hypertrophy, arrhythmias and heart failure are serious outcomes of an
overstimulation of renin angiotensin system. Indeed, when the type 1 angio-
tensin II (ANGII) receptor (AT1R) is overexpressed in a cardiac-specific
manner in mice all of these pathologies are recapitulated. Nonetheless, the
mechanism underlying these pathologies remain incompletely understood. Pre-
viously, we have shown that chronic stimulation of AT1R caused significant
decreases in ventricular potassium and calcium currents. To further investigate
the AT1R mediated regulation of ion channels, we examined the cardiac so-
dium current (INa) in AT1R mice. To distinguish the effect of a direct AT1R
overexpression from AT1R induced hypertrophy, mice were used before (50-
day, 50d) and after (6-month, 6m) the development of cardiac hypertrophy.
Surface ECG recordings showed that QRS complex was prolonged indepen-
dently of cardiac remodelling in AT1R mice compared to controls. (50d:
CTL: 17.050.4 ms, n=11 and AT1R: 22.251.5 ms, n=7 and 6m: CTL:
17.050.6 ms, n=9 and AT1R: 21.750.6 ms, n=9). Current-clamp recordings
revealed that the maximal velocity of the action potential (AP) upstroke
(Vmax) was reduced to a similar extent in AT1R mice of both age groups
compared to controls (50d: CTL: 10754, n=20, AT1R: 7654, n=22; 6m:
CTL: 11157, n=12, AT1R: 6455, n=13). Lastly, voltage-clamp recordings
showed a 65% reduction in INa density in AT1R mice of both ages (at
45mV, 50d: CTL: 41.852.6 pA/pF, n=26, AT1R: 14.151.1 pA/pF,
n=23; 6m: CTL: 38.053.1 pA/pF, n=13 and AT1R: 13.552.1 pA/pF,
n=7). In conclusion, overstimulation of the AT1R pathways leads to INa reduc-
tion and results in severe cardiac electrical disturbances which occurred before
the development of cardiac hypertrophy suggesting they are not secondary to
hypertrophy.
1662-Pos Board B392
Differential Thermosensitivity in Nav1.5 Mutations Associated with Long
QT and Brugada Syndromes
Mena Abdelsayed, Peter C. Ruben.
Simon Fraser University, Burnaby, BC, Canada.
Some cardiac arrhythmias are associated with mutations in the cardiac voltage-
gated sodium channel (NaV1.5), including long QT3 syndrome (gain-of-func-
tion mutations) and Brugada syndrome (loss-of-function mutations). Two mu-
tations, E1784K and R1193Q are associated with both syndromes, whereas
R376H is a Brugada syndrome mutation. We tested the effects of temperature
on gating in wild-type (WT) NaV1.5 and these three mutations. Whole-cell
patch clamp experiments were performed on CHO cells transiently transfected
with the NaV1.5 asubunit, the b1-subunit, and eGFP. Voltage-clamp proto-
cols were performed at either 10 C, 22 C, or 34 C. Conductance in WT was
not temperature dependent compared to the mutant channels, all of which
showed a depolarizing shift in the midpoint of the conductance curve at
10C. A significant hyperpolarizing shift in steady-state fast inactivation was
seen when temperature increased to 34 C in R1193Q. In WT and R376H,
persistent current was greater at 10 oC than at 22 oC. In contrast, persistent cur-
rent both R1193Q and E1784K had U-shaped temperature dependence in which
persistent current increased when temperature was changed from 22 C to 34
C and from 22 oC to 10 oC. E1784K and R376H had greater use-dependent
inactivation with increasing temperatures (22 C to 34 C), whereas use-
dependent inactivation in R1193Q had no thermosensitivity. This is consistent
with previous results, which show that both the E1784K and R1193Q are mixed
syndrome mutations. Although elevated temperatures may trigger long QT syn-
drome, the large stabilization in fast inactivation for R1193Q and the increase
in use-dependence for E1784K suggest a mixed syndrome phenotypic expres-
sion. The loss of function in R376H, associated with Brugada-syndrome, is
